Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

MATTHEW COLLIN

NPI
1063099364
CMS profile
11687622
Location
HOUSTON, TX

General Payments · PY2023–2025

$1,462.86

  • Reported across 27 records
  • CMS publication 2026-06-30

Latest program year · PY2025

$557.70

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2025 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $557.70 16

By paying entity

PY2025 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $127.25 6
Alexion Pharmaceuticals, Inc. $112.79 1
Vanda Pharmaceuticals Inc. $96.94 1
EMD Serono, Inc. $69.54 2
UCB, Inc. $56.16 2
Biogen, Inc. $48.83 2
Genentech USA, Inc. $23.89 1
Grifols USA, LLC $22.30 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $100.13 1
PY2024 $805.03 10
PY2025 $557.70 16

Payment records · PY2025 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2025 20232024 Record-level detail is published for PY2025; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $112.79 08/14/2025 Food and Beverage Undisputed 06/30/2026 1211400652 CMS
Biogen, Inc. $29.66 07/16/2025 Food and Beverage Undisputed 06/30/2026 1208369492 CMS
Biogen, Inc. $19.17 09/04/2025 Food and Beverage Undisputed 06/30/2026 1208362871 CMS
EMD Serono, Inc. $42.90 10/20/2025 Food and Beverage Undisputed 06/30/2026 1236872288 CMS
EMD Serono, Inc. $26.64 11/17/2025 Food and Beverage Undisputed 06/30/2026 1236872378 CMS
Genentech USA, Inc. $23.89 10/28/2025 Food and Beverage Undisputed 06/30/2026 1211545947 CMS
Grifols USA, LLC $22.30 07/21/2025 Food and Beverage Undisputed 06/30/2026 1249579350 CMS
Novartis Pharmaceuticals Corporation $32.56 08/11/2025 Food and Beverage Undisputed 06/30/2026 1200205699 CMS
Novartis Pharmaceuticals Corporation $21.66 09/03/2025 Food and Beverage Undisputed 06/30/2026 1200205721 CMS
Novartis Pharmaceuticals Corporation $15.34 09/22/2025 Food and Beverage Undisputed 06/30/2026 1200205737 CMS
Novartis Pharmaceuticals Corporation $20.20 10/15/2025 Food and Beverage Undisputed 06/30/2026 1200205741 CMS
Novartis Pharmaceuticals Corporation $22.97 12/03/2025 Food and Beverage Undisputed 06/30/2026 1200054571 CMS
Novartis Pharmaceuticals Corporation $14.52 12/22/2025 Food and Beverage Undisputed 06/30/2026 1200054579 CMS
UCB, Inc. $31.48 02/27/2025 Food and Beverage Undisputed 06/30/2026 1224486244 CMS
UCB, Inc. $24.68 08/05/2025 Food and Beverage Undisputed 06/30/2026 1224486246 CMS
Vanda Pharmaceuticals Inc. $96.94 12/11/2025 Food and Beverage Undisputed 06/30/2026 1232956909 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2023, 2024, 2025
Source files
Dataset page · Bulk file · PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.